{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:34:47Z","timestamp":1793723687306,"version":"4.6.1"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus that effects both pediatrics and adult patients in Canada and is increasing in prevalence. No Canadian focused best practice recommendations currently exist to guide clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study used a modified Delphi technique to develop evidence and expert opinion-based recommendations for providing care for patients with EoE. The Delphi process consisted of 3 rounds of quantitative surveys and qualitative consensus meetings. Experts were included in the Delphi if they had experience caring for EoE patients in Canada within one of the following professional groups: allergist, adult gastroenterologists, pathologists, pediatric gastroenterologists, and dieticians.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Delphi rounds were completed between May 1, 2024, and June 30, 2024. A total of 31 experts in EoE care from across Canada were recruited to participate in the Delphi consensus process. All participants completed all three rounds of Delphi surveys. The final statement includes 38 recommendations for the care of patients with EoE organized into three sections: definition, diagnosis, and management.\u00a0A Table of research gaps is provided to stimulate further knowledge development on this topic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This consensus statement includes actionable recommendations to support quality care of patients with EoE at any age across Canada. We encourage EoE centers in Canada to come together in a multi-disciplinary form to not only provide clinical care but also do much needed research on Canadian specific topics and gaps in EoE care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-025-00993-0","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:19:49Z","timestamp":1762521589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Recommendations for the diagnosis and management of eosinophilic esophagitis in adults and children in Canada: a Delphi consensus project"],"prefix":"10.1186","volume":"21","author":[{"given":"Vishal","family":"Avinashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milli","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth A.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen","family":"Amhaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha T.","family":"Temirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqqas","family":"Afif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhandapani","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice","family":"Barkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina El","family":"Demellawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Erdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hien Q.","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir C.","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Grzywacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Jeimy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hin Hin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Lacuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Mayrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison","family":"Petropolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sherlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Tardio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy K.","family":"Vander Leek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Vurzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Xenodemetropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"Suppl 2","key":"993_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-018-0287-0","volume":"14","author":"S Carr","year":"2018","unstructured":"Carr S, Chan ES, Watson W. Eosinophilic esophagitis. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):58. https:\/\/doi.org\/10.1186\/s13223-018-0287-0.","journal-title":"Allergy Asthma Clin Immunol"},{"key":"993_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102183","volume":"63","author":"AY Lam","year":"2022","unstructured":"Lam AY, Ma C, Lee JK, Bredenoord AJ. Eosinophilic esophagitis: new molecules, better life? Curr Opin Pharmacol. 2022;63:102183. https:\/\/doi.org\/10.1016\/j.coph.2022.102183.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"993_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaci.2019.11.011","volume":"145","author":"NP Gonsalves","year":"2020","unstructured":"Gonsalves NP, Aceves SS. Diagnosis and treatment of eosinophilic esophagitis. J Allergy Clin Immunol. 2020;145(1):1\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2019.11.011.","journal-title":"J Allergy Clin Immunol"},{"key":"993_CR4","unstructured":"Roussel J, Pandit S. Eosinophilic Esophagitis. Published online August 8, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459297\/"},{"issue":"7","key":"993_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s00106-018-0516-3","volume":"66","author":"C G\u00f3rriz Gil","year":"2018","unstructured":"G\u00f3rriz Gil C, Matallana Royo V, \u00c1lvarez Montero \u00d3, et al. Eosinophilic esophagitis: an underdiagnosed cause of dysphagia and food impaction to be recognized by otolaryngologists. HNO. 2018;66(7):534\u201342. https:\/\/doi.org\/10.1007\/s00106-018-0516-3.","journal-title":"HNO"},{"issue":"10","key":"993_CR6","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1016\/j.cgh.2022.12.018","volume":"21","author":"U Arnim","year":"2023","unstructured":"Arnim U, Biedermann L, Aceves SS, et al. Monitoring patients with eosinophilic esophagitis in routine clinical practice: International expert recommendations. Clin Gastroenterol Hepatol. 2023;21(10):2526\u201333. https:\/\/doi.org\/10.1016\/j.cgh.2022.12.018.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"993_CR7","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1053\/j.gastro.2007.08.017","volume":"133","author":"GT Furuta","year":"2007","unstructured":"Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133(4):1342\u201363. https:\/\/doi.org\/10.1053\/j.gastro.2007.08.017.","journal-title":"Gastroenterology"},{"issue":"6","key":"993_CR8","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1053\/j.gastro.2020.02.038","volume":"158","author":"I Hirano","year":"2020","unstructured":"Hirano I, Chan ES, Rank MA, et al. AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis. Gastroenterology. 2020;158(6):1776\u201386. https:\/\/doi.org\/10.1053\/j.gastro.2020.02.038.","journal-title":"Gastroenterology"},{"issue":"8","key":"993_CR9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1136\/gutjnl-2022-327326","volume":"71","author":"A Dhar","year":"2022","unstructured":"Dhar A, Haboubi HN, Attwood SE, et al. British society of gastroenterology (BSG) and British society of paediatric gastroenterology, hepatology and nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut. 2022;71(8):1459\u201387. https:\/\/doi.org\/10.1136\/gutjnl-2022-327326.","journal-title":"Gut"},{"issue":"1","key":"993_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.14309\/ajg.0000000000003194","volume":"120","author":"ES Dellon","year":"2025","unstructured":"Dellon ES, Muir AB, Katzka DA, et al. ACG clinical guideline: diagnosis and management of eosinophilic esophagitis. Am J Gastroenterol. 2025;120(1):31\u201359. https:\/\/doi.org\/10.14309\/ajg.0000000000003194.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"993_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1136\/ebnurs-2020-103303","volume":"23","author":"D Barrett","year":"2020","unstructured":"Barrett D, Heale R. What are Delphi studies? Evid Based Nurs. 2020;23(3):68\u20139. https:\/\/doi.org\/10.1136\/ebnurs-2020-103303.","journal-title":"Evid Based Nurs"},{"issue":"1","key":"993_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.anai.2022.10.026","volume":"130","author":"B Underwood","year":"2023","unstructured":"Underwood B, Troutman TD, Schwartz JT. Breaking down the complex pathophysiology of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2023;130(1):28\u201339. https:\/\/doi.org\/10.1016\/j.anai.2022.10.026.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"993_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.815842","volume":"12","author":"F Racca","year":"2022","unstructured":"Racca F, Pellegatta G, Cataldo G, et al. Type 2 inflammation in eosinophilic esophagitis: from pathophysiology to therapeutic targets. Front Physiol. 2022;12:815842. https:\/\/doi.org\/10.3389\/fphys.2021.815842.","journal-title":"Front Physiol"},{"issue":"9","key":"993_CR14","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/ajg.2015.247","volume":"110","author":"BD Van Rhijn","year":"2015","unstructured":"Van Rhijn BD, Verheij J, Van Den Bergh Weerman MA, et al. Histological response to fluticasone propionate in patients with eosinophilic esophagitis is associated with improved functional esophageal mucosal integrity. Am J Gastroenterol. 2015;110(9):1289\u201397. https:\/\/doi.org\/10.1038\/ajg.2015.247.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"993_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.13441","volume":"43","author":"\u00c1 Arias","year":"2016","unstructured":"Arias \u00c1, P\u00e9rez-Mart\u00ednez I, Ten\u00edas JM, Lucendo AJ. Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther. 2016;43(1):3\u201315. https:\/\/doi.org\/10.1111\/apt.13441.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"993_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/PG9.0000000000000136","volume":"2","author":"D Burnett","year":"2021","unstructured":"Burnett D, Persad R, Huynh HQ. Incidence of pediatric eosinophilic esophagitis and characterization of the stricturing phenotype in Alberta, Canada. JPGN Rep. 2021;2(4):e136. https:\/\/doi.org\/10.1097\/PG9.0000000000000136.","journal-title":"JPGN Rep"},{"issue":"1","key":"993_CR17","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.14309\/01.ajg.0000703764.57639.01","volume":"115","author":"M Gupta","year":"2020","unstructured":"Gupta M, Woo M, Li D, Nasser Y, Andrews C, Buresi M. S0429 is rise in incidence of eosinophilic esophagitis as a result of increased awareness? A 15-year study population-based study in Calgary, Canada. Am J Gastroenterol. 2020;115(1):S214\u20135. https:\/\/doi.org\/10.14309\/01.ajg.0000703764.57639.01.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"993_CR18","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/apt.12053","volume":"36","author":"AaN Syed","year":"2012","unstructured":"Syed AaN, Andrews CN, Shaffer E, Urbanski SJ, Beck P, Storr M. The rising incidence of eosinophilic oesophagitis is associated with increasing biopsy rates: a population-based study. Aliment Pharmacol Ther. 2012;36(10):950\u20138. https:\/\/doi.org\/10.1111\/apt.12053.","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"993_CR19","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/apt.13129","volume":"41","author":"ES Dellon","year":"2015","unstructured":"Dellon ES, Erichsen R, Baron JA, et al. The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population-based estimates from Denmark. Aliment Pharmacol Ther. 2015;41(7):662\u201370. https:\/\/doi.org\/10.1111\/apt.13129.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"993_CR20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jaci.2011.09.013","volume":"128","author":"P Hruz","year":"2011","unstructured":"Hruz P, Straumann A, Bussmann C, et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County Switzerland. J Allergy Clin Immunol. 2011;128(6):1349-1350.e5. https:\/\/doi.org\/10.1016\/j.jaci.2011.09.013.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"993_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/MEG.0b013e32835a4c95","volume":"25","author":"\u00c1 Arias","year":"2013","unstructured":"Arias \u00c1, Lucendo AJ. Prevalence of eosinophilic oesophagitis in adult patients in a central region of Spain. Eur J Gastroenterol Hepatol. 2013;25(2):208\u201312. https:\/\/doi.org\/10.1097\/MEG.0b013e32835a4c95.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"5","key":"993_CR22","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1053\/j.gastro.2008.02.016","volume":"134","author":"RC Kapel","year":"2008","unstructured":"Kapel RC, Miller JK, Torres C, Aksoy S, Lash R, Katzka DA. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology. 2008;134(5):1316\u201321. https:\/\/doi.org\/10.1053\/j.gastro.2008.02.016.","journal-title":"Gastroenterology"},{"issue":"3","key":"993_CR23","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jaci.2006.10.044","volume":"119","author":"AH Assa\u2019ad","year":"2007","unstructured":"Assa\u2019ad AH, Putnam PE, Collins MH, et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol. 2007;119(3):731\u20138. https:\/\/doi.org\/10.1016\/j.jaci.2006.10.044.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"993_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/1756283X10384172","volume":"4","author":"J Ricker","year":"2011","unstructured":"Ricker J, McNear S, Cassidy T, et al. Routine screening for eosinophilic esophagitis in patients presenting with dysphagia. Ther Adv Gastroenterol. 2011;4(1):27\u201335. https:\/\/doi.org\/10.1177\/1756283X10384172.","journal-title":"Ther Adv Gastroenterol"},{"issue":"5","key":"993_CR25","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaip.2015.04.016","volume":"3","author":"T Teoh","year":"2015","unstructured":"Teoh T, Koo C, Avinashi V, Chan ES. Characterization of ethnicity among children with eosinophilic esophagitis in British Columbia, Canada. J Allergy Clin Immunol Pract. 2015;3(5):803\u20134. https:\/\/doi.org\/10.1016\/j.jaip.2015.04.016.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"993_CR26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/MCG.0000000000000879","volume":"51","author":"BD van Rhijn","year":"2017","unstructured":"van Rhijn BD, Bredenoord AJ. Management of eosinophilic esophagitis based on pathophysiological evidence. J Clin Gastroenterol. 2017;51(8):659\u201368. https:\/\/doi.org\/10.1097\/MCG.0000000000000879.","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"993_CR27","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.jaip.2018.05.010","volume":"6","author":"DA Hill","year":"2018","unstructured":"Hill DA, Grundmeier RW, Ramos M, Spergel JM. Eosinophilic esophagitis is a late manifestation of the allergic march. J Allergy Clin Immunol Pract. 2018;6(5):1528\u201333. https:\/\/doi.org\/10.1016\/j.jaip.2018.05.010.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"993_CR28","doi-asserted-by":"publisher","first-page":"e957","DOI":"10.1016\/j.cgh.2020.11.023","volume":"20","author":"K Peterson","year":"2022","unstructured":"Peterson K, Clayton F, Qeadan F, et al. Esophageal eosinophilia is common among relatives of eosinophilic esophagitis patients. Clin Gastroenterol Hepatol. 2022;20(5):e957\u201363. https:\/\/doi.org\/10.1016\/j.cgh.2020.11.023.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"13","key":"993_CR29","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/jama.2021.14920","volume":"326","author":"A Muir","year":"2021","unstructured":"Muir A, Falk GW. Eosinophilic esophagitis: a review. JAMA. 2021;326(13):1310\u20138. https:\/\/doi.org\/10.1001\/jama.2021.14920.","journal-title":"JAMA"},{"issue":"6","key":"993_CR30","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1053\/j.gastro.2013.08.015","volume":"145","author":"AM Schoepfer","year":"2013","unstructured":"Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145(6):1230\u20136. https:\/\/doi.org\/10.1053\/j.gastro.2013.08.015.","journal-title":"Gastroenterology"},{"issue":"1","key":"993_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jpr3.12149","volume":"6","author":"D Burnett","year":"2024","unstructured":"Burnett D, Avinashi V, Hoang T, et al. A Canadian multicenter pediatric eosinophilic esophagitis cohort: evidence for a nondilation approach to esophageal narrowing. JPGN Rep. 2024;6(1):19\u201326. https:\/\/doi.org\/10.1002\/jpr3.12149.","journal-title":"JPGN Rep."},{"issue":"2","key":"993_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/diagnostics14020218","volume":"14","author":"S Casabona-Franc\u00e9s","year":"2024","unstructured":"Casabona-Franc\u00e9s S, Sanz-Garc\u00eda A, Ortega GJ, et al. A new method to evaluate lower esophageal distension capacity in eosinophilic esophagitis by using functional lumen imaging probe (EndoFLIP\u2122). Diagn Basel Switz. 2024;14(2):218. https:\/\/doi.org\/10.3390\/diagnostics14020218.","journal-title":"Diagn Basel Switz"},{"issue":"4","key":"993_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.gie.2023.10.048","volume":"99","author":"DA Carlson","year":"2024","unstructured":"Carlson DA, Hirano I, Gonsalves N, et al. Composite score of physiomechanical esophageal function using functional lumen imaging probe panometry in eosinophilic esophagitis. Gastrointest Endosc. 2024;99(4):499-510.e1. https:\/\/doi.org\/10.1016\/j.gie.2023.10.048.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"993_CR34","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","volume":"155","author":"ES Dellon","year":"2018","unstructured":"Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis proceedings of the AGREE conference. Gastroenterology. 2018;155(4):1022\u201333. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.009.","journal-title":"Gastroenterology"},{"issue":"5","key":"993_CR35","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jaip.2018.05.038","volume":"6","author":"M Chehade","year":"2018","unstructured":"Chehade M, Jones SM, Pesek RD, et al. Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the consortium for food allergy research. J Allergy Clin Immunol Pract. 2018;6(5):1534-1544.e5. https:\/\/doi.org\/10.1016\/j.jaip.2018.05.038.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"7","key":"993_CR36","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0016-5107(05)00313-5","volume":"61","author":"TK Desai","year":"2005","unstructured":"Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61(7):795\u2013801. https:\/\/doi.org\/10.1016\/S0016-5107(05)00313-5.","journal-title":"Gastrointest Endosc"},{"issue":"4","key":"993_CR37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1055\/s-2007-966216","volume":"39","author":"S M\u00fcller","year":"2007","unstructured":"M\u00fcller S, P\u00fchl S, Vieth M, Stolte M. Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy. 2007;39(4):339\u201344. https:\/\/doi.org\/10.1055\/s-2007-966216.","journal-title":"Endoscopy"},{"issue":"1","key":"993_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/MPG.0b013e3181788282","volume":"48","author":"JM Spergel","year":"2009","unstructured":"Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48(1):30\u20136. https:\/\/doi.org\/10.1097\/MPG.0b013e3181788282.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"993_CR39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1573396315666191004110549","volume":"16","author":"A De Matteis","year":"2020","unstructured":"De Matteis A, Pagliaro G, Corleto VD, et al. Eosinophilic esophagitis in children: clinical findings and diagnostic approach. Curr Pediatr Rev. 2020;16(3):206\u201314. https:\/\/doi.org\/10.2174\/1573396315666191004110549.","journal-title":"Curr Pediatr Rev"},{"key":"993_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/CEG.S364994","volume":"15","author":"T Alhmoud","year":"2022","unstructured":"Alhmoud T, Ghazaleh S, Ghanim M, Redfern RE. The risk of esophageal food impaction in eosinophilic esophagitis patients: the role of clinical and socioeconomic factors. Clin Exp Gastroenterol. 2022;15:153\u201361. https:\/\/doi.org\/10.2147\/CEG.S364994.","journal-title":"Clin Exp Gastroenterol"},{"issue":"5","key":"993_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1055\/s-0042-100456","volume":"48","author":"M Birk","year":"2016","unstructured":"Birk M, Bauerfeind P, Deprez PH, et al. Removal of foreign bodies in the upper gastrointestinal tract in adults: European society of gastrointestinal endoscopy (ESGE) clinical guideline. Endoscopy. 2016;48(5):489\u201396. https:\/\/doi.org\/10.1055\/s-0042-100456.","journal-title":"Endoscopy"},{"issue":"4","key":"993_CR42","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.gie.2022.05.013","volume":"96","author":"SS Aceves","year":"2022","unstructured":"Aceves SS, Alexander JA, Baron TH, et al. Endoscopic approach to eosinophilic esophagitis: American society for gastrointestinal endoscopy consensus conference. Gastrointest Endosc. 2022;96(4):576-592.e1. https:\/\/doi.org\/10.1016\/j.gie.2022.05.013.","journal-title":"Gastrointest Endosc"},{"issue":"10","key":"993_CR43","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.14309\/ajg.0000000000002392","volume":"118","author":"H Guo","year":"2023","unstructured":"Guo H, Hamilton P, Enns E, et al. Postendoscopy care for patients presenting with esophageal food bolus impaction: a population-based multicenter cohort study. Am J Gastroenterol. 2023;118(10):1787\u201396. https:\/\/doi.org\/10.14309\/ajg.0000000000002392.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"993_CR44","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jaip.2024.02.006","volume":"12","author":"GT Chua","year":"2024","unstructured":"Chua GT, Dhir A, Cameron SB, et al. Working with surgeons who provide endoscopy in underserved areas for the management of eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2024;12(5):1397\u20138. https:\/\/doi.org\/10.1016\/j.jaip.2024.02.006.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"993_CR45","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ajg.2014.47","volume":"109","author":"ET Jensen","year":"2014","unstructured":"Jensen ET, Hoffman K, Shaheen NJ, Genta RM. Esophageal eosinophilia is increased in rural areas with low population density: results from a national pathology database. Am J Gastroenterol. 2014;109(5):668\u201375. https:\/\/doi.org\/10.1038\/ajg.2014.47.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"993_CR46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/MPG.0b013e3181eb5a9f","volume":"52","author":"JM Spergel","year":"2011","unstructured":"Spergel JM, Book WM, Mays E, et al. Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr. 2011;52(3):300\u20136. https:\/\/doi.org\/10.1097\/MPG.0b013e3181eb5a9f.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"993_CR47","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/apt.12914","volume":"40","author":"J Molina-Infante","year":"2014","unstructured":"Molina-Infante J, Rivas MD, Hernandez-Alonso M, et al. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther. 2014;40(8):955\u201365. https:\/\/doi.org\/10.1111\/apt.12914.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"993_CR48","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/j.cgh.2014.02.037","volume":"12","author":"BD van Rhijn","year":"2014","unstructured":"van Rhijn BD, Weijenborg PW, Verheij J, et al. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12(11):1815-1823.e2. https:\/\/doi.org\/10.1016\/j.cgh.2014.02.037.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"993_CR49","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.dld.2024.02.020","volume":"56","author":"N de Bortoli","year":"2024","unstructured":"de Bortoli N, Visaggi P, Penagini R, et al. The 1st EoETALY consensus on the diagnosis and management of eosinophilic esophagitis-current treatment and monitoring. Dig Liver Dis. 2024;56(7):1173\u201384. https:\/\/doi.org\/10.1016\/j.dld.2024.02.020.","journal-title":"Dig Liver Dis"},{"issue":"9","key":"993_CR50","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cgh.2012.04.019","volume":"10","author":"HP Kim","year":"2012","unstructured":"Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2012;10(9):988-996.e5. https:\/\/doi.org\/10.1016\/j.cgh.2012.04.019.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"12","key":"993_CR51","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.cgh.2009.08.030","volume":"7","author":"ES Dellon","year":"2009","unstructured":"Dellon ES, Gibbs WB, Fritchie KJ, et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7(12):1305\u201313. https:\/\/doi.org\/10.1016\/j.cgh.2009.08.030.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"993_CR52","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","volume":"62","author":"I Hirano","year":"2013","unstructured":"Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62(4):489\u201395. https:\/\/doi.org\/10.1136\/gutjnl-2011-301817.","journal-title":"Gut"},{"issue":"1","key":"993_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1053\/j.gastro.2022.03.025","volume":"163","author":"ES Dellon","year":"2022","unstructured":"Dellon ES, Khoury P, Muir AB, et al. A clinical severity index for eosinophilic esophagitis: development, consensus, and future directions. Gastroenterology. 2022;163(1):59\u201376. https:\/\/doi.org\/10.1053\/j.gastro.2022.03.025.","journal-title":"Gastroenterology"},{"issue":"10","key":"993_CR54","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1016\/j.cgh.2023.03.047","volume":"21","author":"CC Cotton","year":"2023","unstructured":"Cotton CC, Moist SE, McGee SJ, Furuta GT, Aceves SS, Dellon ES. A newly proposed severity index for eosinophilic esophagitis is associated with baseline clinical features and successful treatment response. Clin Gastroenterol Hepatol. 2023;21(10):2534-2542.e1. https:\/\/doi.org\/10.1016\/j.cgh.2023.03.047.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"993_CR55","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.gie.2006.04.037","volume":"64","author":"N Gonsalves","year":"2006","unstructured":"Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64(3):313\u20139. https:\/\/doi.org\/10.1016\/j.gie.2006.04.037.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"993_CR56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cgh.2021.05.053","volume":"20","author":"ES Dellon","year":"2022","unstructured":"Dellon ES, Gonsalves N, Rothenberg ME, et al. Determination of biopsy yield that optimally detects eosinophilic gastritis and\/or duodenitis in a randomized trial of Lirentelimab. Clin Gastroenterol Hepatol. 2022;20(3):535-545.e15. https:\/\/doi.org\/10.1016\/j.cgh.2021.05.053.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"993_CR57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/modpathol.2014.110","volume":"28","author":"ES Dellon","year":"2015","unstructured":"Dellon ES, Speck O, Woodward K, et al. Distribution and variability of esophageal eosinophilia in patients undergoing upper endoscopy. Mod Pathol. 2015;28(3):383\u201390. https:\/\/doi.org\/10.1038\/modpathol.2014.110.","journal-title":"Mod Pathol"},{"issue":"7","key":"993_CR58","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1007\/s10620-009-1005-z","volume":"55","author":"ES Dellon","year":"2010","unstructured":"Dellon ES, Fritchie KJ, Rubinas TC, Woosley JT, Shaheen NJ. Inter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophilia. Dig Dis Sci. 2010;55(7):1940\u20139. https:\/\/doi.org\/10.1007\/s10620-009-1005-z.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"993_CR59","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jaci.2010.05.027","volume":"126","author":"CW DeBrosse","year":"2010","unstructured":"DeBrosse CW, Collins MH, Buckmeier Butz BK, et al. Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982\u20131999. J Allergy Clin Immunol. 2010;126(1):112\u20139. https:\/\/doi.org\/10.1016\/j.jaci.2010.05.027.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"993_CR60","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jaci.2015.05.045","volume":"137","author":"J Rajan","year":"2016","unstructured":"Rajan J, Newbury RO, Anilkumar A, Dohil R, Broide DH, Aceves SS. Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol. 2016;137(1):147-156.e8. https:\/\/doi.org\/10.1016\/j.jaci.2015.05.045.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"993_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/dote.12470","volume":"30","author":"MH Collins","year":"2017","unstructured":"Collins MH, Martin LJ, Alexander ES, et al. Newly developed and validated eosinophilic esophagitis histology scoring system and evidence that it outperforms peak eosinophil count for disease diagnosis and monitoring. Dis Esophagus Off J Int Soc Dis Esophagus. 2017;30(3):1\u20138. https:\/\/doi.org\/10.1111\/dote.12470.","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"issue":"2","key":"993_CR62","doi-asserted-by":"publisher","first-page":"264","DOI":"10.14309\/ajg.0000000000001571","volume":"117","author":"C Ma","year":"2022","unstructured":"Ma C, Jairath V, Feagan BG, et al. Responsiveness of a histologic scoring system compared with peak eosinophil count in eosinophilic esophagitis. Am J Gastroenterol. 2022;117(2):264\u201371. https:\/\/doi.org\/10.14309\/ajg.0000000000001571.","journal-title":"Am J Gastroenterol"},{"key":"993_CR63","doi-asserted-by":"publisher","DOI":"10.1080\/15513815.2022.2028950","author":"J Cruz","year":"2022","unstructured":"Cruz J, Irvine MA, Avinashi V, et al. Application of the eosinophilic esophagitis histology scoring system grade scores in patients at British Columbia Children\u2019s Hospital. Fetal Pediatr Pathol. 2022. https:\/\/doi.org\/10.1080\/15513815.2022.2028950.","journal-title":"Fetal Pediatr Pathol"},{"issue":"1","key":"993_CR64","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/MPG.0000000000003877","volume":"78","author":"A Papadopoulou","year":"2024","unstructured":"Papadopoulou A, Amil-Dias J, Auth MKH, et al. Joint ESPGHAN\/NASPGHAN guidelines on childhood eosinophilic gastrointestinal disorders beyond eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2024;78(1):122\u201352. https:\/\/doi.org\/10.1097\/MPG.0000000000003877.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"993_CR65","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/j.cgh.2021.07.025","volume":"19","author":"BG Sauer","year":"2021","unstructured":"Sauer BG, West A, McGowan EC. Multidisciplinary eosinophilic esophagitis care: a model for comprehensive patient-centered care through shared decision making between gastroenterology, allergy, and nutrition. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2021;19(11):2226\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2021.07.025.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"4","key":"993_CR66","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1136\/bmjebm-2022-112068","volume":"28","author":"VM Montori","year":"2023","unstructured":"Montori VM, Ruissen MM, Hargraves IG, Brito JP, Kunneman M. Shared decision-making as a method of care. BMJ Evid-Based Med. 2023;28(4):213\u20137. https:\/\/doi.org\/10.1136\/bmjebm-2022-112068.","journal-title":"BMJ Evid-Based Med"},{"issue":"6","key":"993_CR67","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1007\/s10620-020-06438-5","volume":"66","author":"JW Chang","year":"2021","unstructured":"Chang JW, Rubenstein JH, Mellinger JL, et al. Motivations, barriers, and outcomes of patient-reported shared decision making in eosinophilic esophagitis. Dig Dis Sci. 2021;66(6):1808\u201317. https:\/\/doi.org\/10.1007\/s10620-020-06438-5.","journal-title":"Dig Dis Sci"},{"issue":"9","key":"993_CR68","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.14309\/ajg.0000000000001850","volume":"117","author":"ML Haasnoot","year":"2022","unstructured":"Haasnoot ML, Safi S, Bredenoord AJ. Poor adherence to medical and dietary treatments in adult patients with eosinophilic esophagitis. Am J Gastroenterol. 2022;117(9):1412\u20138. https:\/\/doi.org\/10.14309\/ajg.0000000000001850.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"993_CR69","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/doab073","volume":"35","author":"JW Chang","year":"2022","unstructured":"Chang JW, Chen VL, Rubenstein JH, Dellon ES, Wallner LP, De Vries R. What patients with eosinophilic esophagitis may not share with their providers: a qualitative assessment of online health communities. Dis Esophagus. 2022;35(6):doab073. https:\/\/doi.org\/10.1093\/dote\/doab073.","journal-title":"Dis Esophagus"},{"issue":"6","key":"993_CR70","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1097\/MPG.0000000000003303","volume":"73","author":"J Robinson","year":"2021","unstructured":"Robinson J, Furuta GT, Hadker N, et al. Transition of care from pediatric to adult care in eosinophilic esophagitis: insights from a patient perspective survey. J Pediatr Gastroenterol Nutr. 2021;73(6):722\u20136. https:\/\/doi.org\/10.1097\/MPG.0000000000003303.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"993_CR71","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/MPG.0000000000001415","volume":"65","author":"S Eluri","year":"2017","unstructured":"Eluri S, Book WM, Kodroff E, et al. Lack of knowledge and low readiness for health care transition in eosinophilic esophagitis and eosinophilic gastroenteritis. J Pediatr Gastroenterol Nutr. 2017;65(1):53\u20137. https:\/\/doi.org\/10.1097\/MPG.0000000000001415.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"993_CR72","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1442-2050.2011.01315.x","volume":"26","author":"ES Dellon","year":"2013","unstructured":"Dellon ES, Jones PD, Martin NB, et al. Health-care transition from pediatric to adult-focused gastroenterology in patients with eosinophilic esophagitis. Dis Esophagus Off J Int Soc Dis Esophagus. 2013;26(1):7\u201313. https:\/\/doi.org\/10.1111\/j.1442-2050.2011.01315.x.","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"},{"issue":"11","key":"993_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050037","volume":"7","author":"X Zhang","year":"2012","unstructured":"Zhang X, Cheng E, Huo X, et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS ONE. 2012;7(11):e50037. https:\/\/doi.org\/10.1371\/journal.pone.0050037.","journal-title":"PLoS ONE"},{"issue":"4","key":"993_CR74","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/jgh.16469","volume":"39","author":"M Muftah","year":"2024","unstructured":"Muftah M, Hartnett DA, Flanagan R, et al. Allergic phenotype identified on allergen testing is associated with proton pump inhibitor nonresponse in eosinophilic esophagitis. J Gastroenterol Hepatol. 2024;39(4):701\u20137. https:\/\/doi.org\/10.1111\/jgh.16469.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"993_CR75","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1053\/j.gastro.2006.08.033","volume":"131","author":"MR Konikoff","year":"2006","unstructured":"Konikoff MR, Noel RJ, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006;131(5):1381\u201391. https:\/\/doi.org\/10.1053\/j.gastro.2006.08.033.","journal-title":"Gastroenterology"},{"issue":"7","key":"993_CR76","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1007\/s10620-016-4110-9","volume":"61","author":"D Albert","year":"2016","unstructured":"Albert D, Heifert TA, Min SB, et al. Comparisons of fluticasone to budesonide in the treatment of eosinophilic esophagitis. Dig Dis Sci. 2016;61(7):1996\u20132001. https:\/\/doi.org\/10.1007\/s10620-016-4110-9.","journal-title":"Dig Dis Sci"},{"key":"993_CR77","doi-asserted-by":"publisher","first-page":"175628482092728","DOI":"10.1177\/1756284820927282","volume":"13","author":"S Miehlke","year":"2020","unstructured":"Miehlke S, Lucendo AJ, Straumann A, Jan Bredenoord A, Attwood S. Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence. Ther Adv Gastroenterol. 2020;13:1756284820927282. https:\/\/doi.org\/10.1177\/1756284820927282.","journal-title":"Ther Adv Gastroenterol"},{"issue":"1","key":"993_CR78","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1053\/j.gastro.2019.03.014","volume":"157","author":"ES Dellon","year":"2019","unstructured":"Dellon ES, Woosley JT, Arrington A, et al. Efficacy of budesonide vs fluticasone for initial treatment of eosinophilic esophagitis in a randomized controlled trial. Gastroenterology. 2019;157(1):65-73.e5. https:\/\/doi.org\/10.1053\/j.gastro.2019.03.014.","journal-title":"Gastroenterology"},{"issue":"5","key":"993_CR79","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ueg2.12533","volume":"12","author":"EJ Laserna-Mendieta","year":"2024","unstructured":"Laserna-Mendieta EJ, Navarro P, Casabona-Franc\u00e9s S, et al. Swallowed topical corticosteroids for eosinophilic esophagitis: utilization and real-world efficacy from the EoE CONNECT registry. United Eur Gastroenterol J. 2024;12(5):585\u201395. https:\/\/doi.org\/10.1002\/ueg2.12533.","journal-title":"United Eur Gastroenterol J"},{"issue":"6","key":"993_CR80","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jaci.2007.10.024","volume":"120","author":"C Blanchard","year":"2007","unstructured":"Blanchard C, Mingler MK, Vicario M, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007;120(6):1292\u2013300. https:\/\/doi.org\/10.1016\/j.jaci.2007.10.024.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"993_CR81","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.cgh.2014.02.039","volume":"12","author":"DA Katzka","year":"2014","unstructured":"Katzka DA, Tadi R, Smyrk TC, et al. Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12(11):1824-1829.e1. https:\/\/doi.org\/10.1016\/j.cgh.2014.02.039.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"993_CR82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/j.1398-9995.2009.02142.x","volume":"65","author":"SS Aceves","year":"2010","unstructured":"Aceves SS, Newbury RO, Chen D, et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy. 2010;65(1):109\u201316. https:\/\/doi.org\/10.1111\/j.1398-9995.2009.02142.x.","journal-title":"Allergy"},{"issue":"9","key":"993_CR83","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/MCG.0000000000000873","volume":"52","author":"S Lipka","year":"2018","unstructured":"Lipka S, Kumar A, Richter JE. Successful esophageal dilation of eosinophilic esophagitis (EoE) patients with a previous postdilation complication: start low and go slow. J Clin Gastroenterol. 2018;52(9):773\u20137. https:\/\/doi.org\/10.1097\/MCG.0000000000000873.","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"993_CR84","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jaci.2017.08.038","volume":"141","author":"J Molina-Infante","year":"2018","unstructured":"Molina-Infante J, Arias \u00c1, Alcedo J, et al. Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: the 2\u20134-6 study. J Allergy Clin Immunol. 2018;141(4):1365\u201372. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.038.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"993_CR85","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1097\/MPG.0000000000002215","volume":"68","author":"A Hoofien","year":"2019","unstructured":"Hoofien A, Dias JA, Malamisura M, et al. Pediatric eosinophilic esophagitis: results of the European retrospective pediatric eosinophilic esophagitis registry (RetroPEER). J Pediatr Gastroenterol Nutr. 2019;68(4):552\u20138. https:\/\/doi.org\/10.1097\/MPG.0000000000002215.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"993_CR86","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S2468-1253(23)00012-2","volume":"8","author":"KL Kliewer","year":"2023","unstructured":"Kliewer KL, Gonsalves N, Dellon ES, et al. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial. Lancet Gastroenterol Hepatol. 2023;8(5):408\u201321. https:\/\/doi.org\/10.1016\/S2468-1253(23)00012-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"993_CR87","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00431-018-3129-7","volume":"177","author":"M Munoz-Persy","year":"2018","unstructured":"Munoz-Persy M, Lucendo AJ. Treatment of eosinophilic esophagitis in the pediatric patient: an evidence-based approach. Eur J Pediatr. 2018;177(5):649\u201363. https:\/\/doi.org\/10.1007\/s00431-018-3129-7.","journal-title":"Eur J Pediatr"},{"issue":"9","key":"993_CR88","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.cgh.2023.01.019","volume":"21","author":"C Mayerhofer","year":"2023","unstructured":"Mayerhofer C, Kavallar AM, Aldrian D, Lindner AK, M\u00fcller T, Vogel GF. Efficacy of elimination diets in eosinophilic esophagitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2023;21(9):2197-2210.e3. https:\/\/doi.org\/10.1016\/j.cgh.2023.01.019.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"993_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.08.023","author":"KL Kliewer","year":"2024","unstructured":"Kliewer KL, Abonia JP, Aceves SS, et al. One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: a\u00a0multisite randomized trial. J Allergy Clin Immunol. 2024. https:\/\/doi.org\/10.1016\/j.jaci.2024.08.023.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"993_CR90","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MPG.0000000000002323","volume":"69","author":"J Robson","year":"2019","unstructured":"Robson J, Laborda T, Fitzgerald S, et al. Avoidant\/restrictive food intake disorder in diet-treated children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2019;69(1):57\u201360. https:\/\/doi.org\/10.1097\/MPG.0000000000002323.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"993_CR91","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1097\/MPG.0000000000001741","volume":"66","author":"P Mehta","year":"2018","unstructured":"Mehta P, Furuta GT, Brennan T, et al. Nutritional state and feeding behaviors of children with eosinophilic esophagitis and gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2018;66(4):603\u20138. https:\/\/doi.org\/10.1097\/MPG.0000000000001741.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"993_CR92","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1080\/1744666X.2020.1801419","volume":"16","author":"M Chehade","year":"2020","unstructured":"Chehade M, Brown S. Elimination diets for eosinophilic esophagitis: making the best choice. Expert Rev Clin Immunol. 2020;16(7):679\u201387. https:\/\/doi.org\/10.1080\/1744666X.2020.1801419.","journal-title":"Expert Rev Clin Immunol"},{"issue":"7","key":"993_CR93","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1053\/j.gastro.2014.02.006","volume":"146","author":"A Arias","year":"2014","unstructured":"Arias A, Gonz\u00e1lez-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146(7):1639\u201348. https:\/\/doi.org\/10.1053\/j.gastro.2014.02.006.","journal-title":"Gastroenterology"},{"issue":"6","key":"993_CR94","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/apt.13953","volume":"45","author":"MJ Warners","year":"2017","unstructured":"Warners MJ, Vlieg-Boerstra BJ, Verheij J, et al. Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients. Aliment Pharmacol Ther. 2017;45(6):777\u201387. https:\/\/doi.org\/10.1111\/apt.13953.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"993_CR95","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/s1542-3565(05)00885-2","volume":"3","author":"CA Liacouras","year":"2005","unstructured":"Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3(12):1198\u2013206. https:\/\/doi.org\/10.1016\/s1542-3565(05)00885-2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"993_CR96","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/ajg.2012.468","volume":"108","author":"KA Peterson","year":"2013","unstructured":"Peterson KA, Byrne KR, Vinson LA, et al. Elemental diet induces histologic response in adult eosinophilic esophagitis. Am J Gastroenterol. 2013;108(5):759\u201366. https:\/\/doi.org\/10.1038\/ajg.2012.468.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"993_CR97","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.anai.2019.01.010","volume":"122","author":"SJ Gottlieb","year":"2019","unstructured":"Gottlieb SJ, Markowitz JE, Dellon ES. New IgE immediate hypersensitivity reactions on reintroduction of food restricted for treatment of eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2019;122(4):419\u201320. https:\/\/doi.org\/10.1016\/j.anai.2019.01.010.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"993_CR98","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaip.2014.08.005","volume":"3","author":"DA Hill","year":"2015","unstructured":"Hill DA, Shuker M, Cianferoni A, et al. The development of IgE-mediated immediate hypersensitivity after the diagnosis of eosinophilic esophagitis to the same food. J Allergy Clin Immunol Pract. 2015;3(1):123\u20134. https:\/\/doi.org\/10.1016\/j.jaip.2014.08.005.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"993_CR99","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.jaip.2017.02.021","volume":"5","author":"L Soller","year":"2017","unstructured":"Soller L, Mill C, Avinashi V, Teoh T, Chan ES. Development of anaphylactic cow\u2019s milk allergy following cow\u2019s milk elimination for eosinophilic esophagitis in a teenager. J Allergy Clin Immunol Pract. 2017;5(5):1413\u20134. https:\/\/doi.org\/10.1016\/j.jaip.2017.02.021.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"993_CR100","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.jaip.2019.09.006","volume":"8","author":"SC Erdle","year":"2020","unstructured":"Erdle SC, Soller L, Avinashi V, Roberts H, Hsu E, Chan ES. Multiple shifting phenotypes with cow\u2019s milk: from eosinophilic esophagitis to immediate hypersensitivity and back again. J Allergy Clin Immunol Pract. 2020;8(3):1117\u20138. https:\/\/doi.org\/10.1016\/j.jaip.2019.09.006.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"993_CR101","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jaip.2015.08.006","volume":"4","author":"A Chang","year":"2016","unstructured":"Chang A, Robison R, Cai M, Singh AM. Natural history of food-triggered atopic dermatitis and development of immediate reactions in children. J Allergy Clin Immunol Pract. 2016;4(2):229-236.e1. https:\/\/doi.org\/10.1016\/j.jaip.2015.08.006.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"14","key":"993_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11144232","volume":"11","author":"N Papapostolou","year":"2022","unstructured":"Papapostolou N, Xepapadaki P, Gregoriou S, Makris M. Atopic dermatitis and food allergy: a complex interplay what we know and what we would like to learn. J Clin Med. 2022;11(14):4232. https:\/\/doi.org\/10.3390\/jcm11144232.","journal-title":"J Clin Med"},{"issue":"2","key":"993_CR103","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cgh.2007.11.008","volume":"6","author":"ET Schaefer","year":"2008","unstructured":"Schaefer ET, Fitzgerald JF, Molleston JP, et al. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol. 2008;6(2):165\u201373. https:\/\/doi.org\/10.1016\/j.cgh.2007.11.008.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"993_CR104","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","volume":"157","author":"AJ Lucendo","year":"2019","unstructured":"Lucendo AJ, Miehlke S, Schlag C, et al. Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial. Gastroenterology. 2019;157(1):74-86.e15. https:\/\/doi.org\/10.1053\/j.gastro.2019.03.025.","journal-title":"Gastroenterology"},{"issue":"5","key":"993_CR105","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1053\/j.gastro.2020.07.039","volume":"159","author":"A Straumann","year":"2020","unstructured":"Straumann A, Lucendo AJ, Miehlke S, et al. Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis. Gastroenterology. 2020;159(5):1672-1685.e5. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.039.","journal-title":"Gastroenterology"},{"key":"993_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.10.034","author":"L Biedermann","year":"2024","unstructured":"Biedermann L, Schlag C, Straumann A, et al. Efficacy and safety of budesonide orodispersible tablets for eosinophilic esophagitis up to 3 years: an open-label extension study. Clin Gastroenterol Hepatol. 2024. https:\/\/doi.org\/10.1016\/j.cgh.2024.10.034.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"993_CR107","unstructured":"U.S. Food and Drug Administration Designation and Approval: Eohilia. Published online February 9, 2024. https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=227406"},{"issue":"1","key":"993_CR108","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/jpn3.12273","volume":"79","author":"N Lendner","year":"2024","unstructured":"Lendner N, Minich NM, Malay S, Sferra TJ, Young DD. Comparison of budesonide vehicles in inducing histologic remission in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2024;79(1):92\u20139. https:\/\/doi.org\/10.1002\/jpn3.12273.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"993_CR109","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S2468-1253(23)00204-2","volume":"8","author":"ME Rothenberg","year":"2023","unstructured":"Rothenberg ME, Dellon ES, Collins MH, et al. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2023;8(11):990\u20131004. https:\/\/doi.org\/10.1016\/S2468-1253(23)00204-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"25","key":"993_CR110","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","volume":"387","author":"ES Dellon","year":"2022","unstructured":"Dellon ES, Rothenberg ME, Collins MH, et al. Dupilumab in adults and adolescents with eosinophilic esophagitis. N Engl J Med. 2022;387(25):2317\u201330. https:\/\/doi.org\/10.1056\/NEJMoa2205982.","journal-title":"N Engl J Med"},{"issue":"1","key":"993_CR111","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2019.09.042","volume":"158","author":"I Hirano","year":"2020","unstructured":"Hirano I, Dellon ES, Hamilton JD, et al. Efficacy of dupilumab in a phase 2 randomized trial of adults with active eosinophilic esophagitis. Gastroenterology. 2020;158(1):111-122.e10. https:\/\/doi.org\/10.1053\/j.gastro.2019.09.042.","journal-title":"Gastroenterology"},{"issue":"6","key":"993_CR112","doi-asserted-by":"publisher","first-page":"S-835","DOI":"10.1016\/S0016-5085(20)32766-9","volume":"158","author":"JD Hamilton","year":"2020","unstructured":"Hamilton JD, Lim WK, Hamon SC, et al. Mo1228 dupilumab normalizes the eosinophilic esophagitis disease transcriptome in adult patients with eosinophilic esophagitis. Gastroenterology. 2020;158(6):S-835. https:\/\/doi.org\/10.1016\/S0016-5085(20)32766-9.","journal-title":"Gastroenterology"},{"issue":"24","key":"993_CR113","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1056\/NEJMoa2312282","volume":"390","author":"M Chehade","year":"2024","unstructured":"Chehade M, Dellon ES, Spergel JM, et al. Dupilumab for eosinophilic esophagitis in patients 1 to 11 years of age. N Engl J Med. 2024;390(24):2239\u201351. https:\/\/doi.org\/10.1056\/NEJMoa2312282.","journal-title":"N Engl J Med"},{"key":"993_CR114","unstructured":"A Study of CDX-0159 in Patients With Eosinophilic Esophagitis (EvolvE) ClinicalTrials.gov ID NCT05774184. Accessed January 10, 2025. https:\/\/clinicaltrials.gov\/study\/NCT05774184"},{"key":"993_CR115","unstructured":"Zemaira Eosinophilic Esophagitis Pilot Study (ZEEPS) ClinicalTrials.gov Identifier: NCT05485155. Accessed January 10, 2024. https:\/\/clinicaltrials.gov\/study\/NCT05485155"},{"issue":"3","key":"993_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031702","volume":"25","author":"E Ridolo","year":"2024","unstructured":"Ridolo E, Barone A, Ottoni M, Peveri S, Montagni M, Nicoletta F. The new therapeutic frontiers in the treatment of eosinophilic esophagitis: biological drugs. Int J Mol Sci. 2024;25(3):1702. https:\/\/doi.org\/10.3390\/ijms25031702.","journal-title":"Int J Mol Sci"},{"key":"993_CR117","unstructured":"CADTH Canadian Drug Expert Committee Recommendation: Budesonide (Jorveza\u2014Avir Pharma Inc.): Indication: Eosinophilic esophagitis [Internet]. Ottawa (ON): Canadian agency for drugs and technologies in health. Published online October 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK567271\/"},{"key":"993_CR118","unstructured":"Ensuring accessible and affordable quality medicines for Canadians. Government of Canada. Published online May 24, 2024. Accessed January 10, 2025. https:\/\/www.canada.ca\/en\/women-gender-equality\/news\/2024\/05\/ensuring-accessible-and-affordable-quality-medicines-for-canadians-pharmacare-legislation-includes-universal-access-to-contraception-and-diabetes-m.html"},{"key":"993_CR119","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/328253","volume":"2012","author":"OI Saadah","year":"2012","unstructured":"Saadah OI, Aburiziza AJ, Abu Shakra RI. Eosinophilic esophagitis in children from Western Saudi Arabia: relative frequency, clinical, pathological, endoscopic, and immunological study. Gastroenterol Res Pract. 2012;2012:328253. https:\/\/doi.org\/10.1155\/2012\/328253.","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"993_CR120","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/apt.14123","volume":"46","author":"FJ Moawad","year":"2017","unstructured":"Moawad FJ, Molina-Infante J, Lucendo AJ, Cantrell SE, Tmanova L, Douglas KM. Systematic review with meta-analysis: endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis. Aliment Pharmacol Ther. 2017;46(2):96\u2013105. https:\/\/doi.org\/10.1111\/apt.14123.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"993_CR121","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.gastha.2024.01.010","volume":"3","author":"DL Snyder","year":"2024","unstructured":"Snyder DL, Alexander JA, Ravi K, Fidler JL, Katzka DA. Course of esophageal strictures in eosinophilic esophagitis using structured esophagram protocol. Gastro Hep Adv. 2024;3(4):448\u201353. https:\/\/doi.org\/10.1016\/j.gastha.2024.01.010.","journal-title":"Gastro Hep Adv"},{"issue":"5","key":"993_CR122","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/ajg.2009.657","volume":"105","author":"AM Schoepfer","year":"2010","unstructured":"Schoepfer AM, Gonsalves N, Bussmann C, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010;105(5):1062\u201370. https:\/\/doi.org\/10.1038\/ajg.2009.657.","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"993_CR123","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1602","volume":"138","author":"DR Stukus","year":"2016","unstructured":"Stukus DR, Kempe E, Leber A, Thornton D, Scherzer R. Use of food allergy panels by pediatric care providers compared with allergists. Pediatrics. 2016;138(6):e20161602. https:\/\/doi.org\/10.1542\/peds.2016-1602.","journal-title":"Pediatrics"},{"issue":"4","key":"993_CR124","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.anai.2023.04.011","volume":"131","author":"CP Parrish","year":"2023","unstructured":"Parrish CP. A review of food allergy panels and their consequences. Ann Allergy Asthma Immunol. 2023;131(4):421\u20136. https:\/\/doi.org\/10.1016\/j.anai.2023.04.011.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"993_CR125","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S1081-1206(10)61151-9","volume":"95","author":"JM Spergel","year":"2005","unstructured":"Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2005;95(4):336\u201343. https:\/\/doi.org\/10.1016\/S1081-1206(10)61151-9.","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"issue":"3","key":"993_CR126","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/apt.13676","volume":"44","author":"H Philpott","year":"2016","unstructured":"Philpott H, Nandurkar S, Royce SG, Thien F, Gibson PR. Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities. Aliment Pharmacol Ther. 2016;44(3):223\u201333. https:\/\/doi.org\/10.1111\/apt.13676.","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"993_CR127","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/apt.13742","volume":"44","author":"J Molina-Infante","year":"2016","unstructured":"Molina-Infante J, Lucendo AJ. Letter: dietary therapy in eosinophilic oesophagitis: do not test, just eliminate and reintroduce the most common food triggers. Aliment Pharmacol Ther. 2016;44(8):904\u20135. https:\/\/doi.org\/10.1111\/apt.13742.","journal-title":"Aliment Pharmacol Ther"},{"issue":"19","key":"993_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11195631","volume":"11","author":"C Pitsios","year":"2022","unstructured":"Pitsios C, Vassilopoulou E, Pantavou K, et al. Allergy-test-based elimination diets for the treatment of eosinophilic esophagitis: a systematic review of their efficacy. J Clin Med. 2022;11(19):5631. https:\/\/doi.org\/10.3390\/jcm11195631.","journal-title":"J Clin Med"},{"issue":"1\u20132","key":"993_CR129","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000357077","volume":"32","author":"BK Ballmer-Weber","year":"2014","unstructured":"Ballmer-Weber BK. Value of allergy tests for the diagnosis of food allergy. Dig Dis Basel Switz. 2014;32(1\u20132):84\u20138. https:\/\/doi.org\/10.1159\/000357077.","journal-title":"Dig Dis Basel Switz"},{"issue":"3","key":"993_CR130","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1053\/j.gastro.2014.05.036","volume":"147","author":"F Clayton","year":"2014","unstructured":"Clayton F, Fang JC, Gleich GJ, et al. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 2014;147(3):602\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2014.05.036.","journal-title":"Gastroenterology"},{"issue":"1","key":"993_CR131","doi-asserted-by":"publisher","DOI":"10.1080\/28338073.2023.2230033","volume":"12","author":"K Day","year":"2023","unstructured":"Day K, Bredenoord AJ, Skypala I, et al. Addressing educational gaps through multidisciplinary team education in eosinophilic oesophagitis management. J CME. 2023;12(1):2230033. https:\/\/doi.org\/10.1080\/28338073.2023.2230033.","journal-title":"J CME"},{"issue":"3","key":"993_CR132","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113483","volume":"19","author":"D Loizou","year":"2015","unstructured":"Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan L, et al. A pilot study of omalizumab in eosinophilic esophagitis. PLoS ONE. 2015;19(3):e0113483. https:\/\/doi.org\/10.1371\/journal.pone.0113483.","journal-title":"PLoS ONE"},{"issue":"4","key":"993_CR133","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/MOG.0000000000000746","volume":"37","author":"W Woo","year":"2021","unstructured":"Woo W, Aceves SS. The role of the allergist in the management of eosinophilic esophagitis. Curr Opin Gastroenterol. 2021;37(4):390\u20136. https:\/\/doi.org\/10.1097\/MOG.0000000000000746.","journal-title":"Curr Opin Gastroenterol"},{"issue":"12","key":"993_CR134","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1016\/j.jaip.2023.08.012","volume":"11","author":"BE Wilson","year":"2023","unstructured":"Wilson BE, Meltzer EC, Wright BL. Ethical implications of continuing oral immunotherapy after the development of eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2023;11(12):3638\u201344. https:\/\/doi.org\/10.1016\/j.jaip.2023.08.012.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"993_CR135","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.anai.2022.12.014","volume":"130","author":"SS Aceves","year":"2023","unstructured":"Aceves SS, Dellon ES, Greenhawt M, Hirano I, Liacouras CA, Spergel JM. Clinical guidance for the use of dupilumab in eosinophilic esophagitis: a yardstick. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2023;130(3):371\u20138. https:\/\/doi.org\/10.1016\/j.anai.2022.12.014.","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"issue":"10","key":"993_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2024.100968","volume":"17","author":"E Ridolo","year":"2024","unstructured":"Ridolo E, Nicoletta F, Lombardi C, Passalacqua G, Senna G, Canonica GW. Eosinophilic esophagitis and inhalant antigens: pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment. World Allergy Organ J. 2024;17(10):100968. https:\/\/doi.org\/10.1016\/j.waojou.2024.100968.","journal-title":"World Allergy Organ J"},{"issue":"4","key":"993_CR137","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2036.2009.04199.x","volume":"31","author":"FJ Moawad","year":"2010","unstructured":"Moawad FJ, Veerappan GR, Lake JM, et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31(4):509\u201315. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04199.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"993_CR138","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/all.12767","volume":"70","author":"AJ Lucendo","year":"2015","unstructured":"Lucendo AJ, Arias \u00c1, Redondo-Gonz\u00e1lez O, Gonz\u00e1lez-Cervera J. Seasonal distribution of initial diagnosis and clinical recrudescence of eosinophilic esophagitis: a systematic review and meta-analysis. Allergy. 2015;70(12):1640\u201350. https:\/\/doi.org\/10.1111\/all.12767.","journal-title":"Allergy"},{"issue":"3","key":"993_CR139","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.anai.2018.12.013","volume":"122","author":"CC Reed","year":"2019","unstructured":"Reed CC, Iglesia EGA, Commins SP. Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens. Ann Allergy Asthma Immunol. 2019;122(3):296\u2013301. https:\/\/doi.org\/10.1016\/j.anai.2018.12.013.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"9","key":"993_CR140","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1016\/j.jaip.2021.07.032","volume":"9","author":"A Cianferoni","year":"2021","unstructured":"Cianferoni A, Jensen E, Davis CM. The role of the environment in eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2021;9(9):3268\u201374. https:\/\/doi.org\/10.1016\/j.jaip.2021.07.032.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"993_CR141","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/dox122","author":"D Letner","year":"2018","unstructured":"Letner D, Farris A, Khalili H, Garber J. Pollen-food allergy syndrome is a common allergic comorbidity in adults with eosinophilic esophagitis. Dis Esophagus Off J Int Soc Dis Esophagus. 2018. https:\/\/doi.org\/10.1093\/dote\/dox122.","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus."},{"issue":"4","key":"993_CR142","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.anai.2019.07.022","volume":"123","author":"G Carlson","year":"2019","unstructured":"Carlson G, Coop C. Pollen food allergy syndrome (PFAS): a review of current available literature. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2019;123(4):359\u201365. https:\/\/doi.org\/10.1016\/j.anai.2019.07.022.","journal-title":"Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol"},{"issue":"6","key":"993_CR143","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.anai.2014.08.004","volume":"113","author":"AJ Lucendo","year":"2014","unstructured":"Lucendo AJ, Arias A, Tenias JM. Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2014;113(6):624\u20139. https:\/\/doi.org\/10.1016\/j.anai.2014.08.004.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"21","key":"993_CR144","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","volume":"379","author":"BP Vickery","year":"2018","unstructured":"PALISADE Group of Clinical Investigators, Vickery BP, Vereda A, et al. AR101 oral immunotherapy for peanut allergy. N Engl J Med. 2018;379(21):1991\u20132001. https:\/\/doi.org\/10.1056\/NEJMoa1812856.","journal-title":"N Engl J Med"},{"issue":"8","key":"993_CR145","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.jaip.2019.04.010","volume":"7","author":"L Soller","year":"2019","unstructured":"Soller L, Abrams EM, Carr S, et al. First real-world safety analysis of preschool peanut oral immunotherapy. J Allergy Clin Immunol Pract. 2019;7(8):2759-2767.e5. https:\/\/doi.org\/10.1016\/j.jaip.2019.04.010.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"6","key":"993_CR146","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.jaci.2024.04.010","volume":"153","author":"CM Burk","year":"2024","unstructured":"Burk CM, Shreffler WG. Triggers for eosinophilic esophagitis (EoE): the intersection of food allergy and EoE. J Allergy Clin Immunol. 2024;153(6):1500\u20139. https:\/\/doi.org\/10.1016\/j.jaci.2024.04.010.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"993_CR147","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cgh.2020.05.019","volume":"19","author":"BL Wright","year":"2021","unstructured":"Wright BL, Fernandez-Becker NQ, Kambham N, et al. Gastrointestinal eosinophil responses in a longitudinal, randomized trial of peanut oral immunotherapy. Clin Gastroenterol Hepatol. 2021;19(6):1151-1159.e14. https:\/\/doi.org\/10.1016\/j.cgh.2020.05.019.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"993_CR148","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jaip.2017.04.037","volume":"6","author":"AC Barbosa","year":"2018","unstructured":"Barbosa AC, Castro FM, Meireles PR, et al. Eosinophilic esophagitis: latent disease in patients with anaphylactic reaction to cow\u2019s milk. J Allergy Clin Immunol Pract. 2018;6(2):451-456.e1. https:\/\/doi.org\/10.1016\/j.jaip.2017.04.037.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"993_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-020-0413-7","volume":"16","author":"P B\u00e9gin","year":"2020","unstructured":"B\u00e9gin P, Chan ES, Kim H, et al. CSACI guidelines for the ethical, evidence-based and patient-oriented clinical practice of oral immunotherapy in IgE-mediated food allergy. Allergy Asthma Clin Immunol. 2020;16:20. https:\/\/doi.org\/10.1186\/s13223-020-0413-7.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"12","key":"993_CR150","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1111\/cea.14219","volume":"52","author":"M Garc\u00eda Vega","year":"2022","unstructured":"Garc\u00eda Vega M, Fern\u00e1ndez-Fern\u00e1ndez S, Echeverr\u00eda Zudaire L, et al. Long-term medical treatment efficacy in patients with eosinophilic oesophagitis and oral food immunotherapy. Clin Exp Allergy. 2022;52(12):1440\u20133. https:\/\/doi.org\/10.1111\/cea.14219.","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"993_CR151","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jaip.2022.11.010","volume":"11","author":"N Epstein-Rigbi","year":"2023","unstructured":"Epstein-Rigbi N, Elizur A, Levy MB, et al. Treatment of oral immunotherapy-associated eosinophilic esophagitis. J Allergy Clin Immunol Pract. 2023;11(4):1303-1305.e2. https:\/\/doi.org\/10.1016\/j.jaip.2022.11.010.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"993_CR152","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.jaip.2022.11.015","volume":"11","author":"GT Chua","year":"2023","unstructured":"Chua GT, Chan ES, Invik R, et al. How we manage gastrointestinal symptoms during oral immunotherapy through a shared decision-making process: a practical guide for the community practitioner. J Allergy Clin Immunol Pract. 2023;11(4):1049\u201355. https:\/\/doi.org\/10.1016\/j.jaip.2022.11.015.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"993_CR153","doi-asserted-by":"publisher","first-page":"175628482110686","DOI":"10.1177\/17562848211068665","volume":"15","author":"S Feo-Ortega","year":"2022","unstructured":"Feo-Ortega S, Lucendo AJ. Evidence-based treatments for eosinophilic esophagitis: insights for the clinician. Ther Adv Gastroenterol. 2022;15:17562848211068664. https:\/\/doi.org\/10.1177\/17562848211068665.","journal-title":"Ther Adv Gastroenterol"},{"issue":"1","key":"993_CR154","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12876-023-02703-9","volume":"23","author":"T Sia","year":"2023","unstructured":"Sia T, Cunningham E, Miller M, et al. Food elimination diet is a viable alternative therapy for eosinophilic esophagitis responsive to proton pump inhibitors. BMC Gastroenterol. 2023;23(1):60. https:\/\/doi.org\/10.1186\/s12876-023-02703-9.","journal-title":"BMC Gastroenterol"},{"issue":"13","key":"993_CR155","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1016\/j.cgh.2019.03.009","volume":"17","author":"CC Reed","year":"2019","unstructured":"Reed CC, Tappata M, Eluri S, Shaheen NJ, Dellon ES. Combination therapy with elimination diet and corticosteroids is effective for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2019;17(13):2800\u20132. https:\/\/doi.org\/10.1016\/j.cgh.2019.03.009.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"993_CR156","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1053\/j.gastro.2015.11.004","volume":"150","author":"E Safroneeva","year":"2016","unstructured":"Safroneeva E, Straumann A, Coslovsky M, et al. Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis. Gastroenterology. 2016;150(3):581-590.e4. https:\/\/doi.org\/10.1053\/j.gastro.2015.11.004.","journal-title":"Gastroenterology"},{"issue":"2","key":"993_CR157","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/MPG.0b013e31817f0197","volume":"48","author":"S Pentiuk","year":"2009","unstructured":"Pentiuk S, Putnam PE, Collins MH, Rothenberg ME. Dissociation between symptoms and histological severity in pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2009;48(2):152\u201360. https:\/\/doi.org\/10.1097\/MPG.0b013e31817f0197.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"993_CR158","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ueg2.12216","volume":"10","author":"L Bon","year":"2022","unstructured":"Bon L, Safroneeva E, Bussmann C, et al. Close follow-up is associated with fewer stricture formation and results in earlier detection of histological relapse in the long-term management of eosinophilic esophagitis. United Eur Gastroenterol J. 2022;10(3):308\u201318. https:\/\/doi.org\/10.1002\/ueg2.12216.","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"993_CR159","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/apt.18382","volume":"61","author":"A Rivas","year":"2025","unstructured":"Rivas A, Ahmed NS, Yuan Y, et al. Meta-analysis: evaluating placebo rates across outcomes in eosinophilic oesophagitis randomised controlled trials. Aliment Pharmacol Ther. 2025;61(1):32\u201343. https:\/\/doi.org\/10.1111\/apt.18382.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"993_CR160","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/jgh3.12059","volume":"2","author":"R Eke","year":"2018","unstructured":"Eke R, Li T, White A, Tariq T, Markowitz J, Lenov A. Systematic review of histological remission criteria in eosinophilic esophagitis. JGH Open. 2018;2(4):158\u201365. https:\/\/doi.org\/10.1002\/jgh3.12059.","journal-title":"JGH Open"},{"issue":"4","key":"993_CR161","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1053\/j.gastro.2019.09.052","volume":"158","author":"I Hirano","year":"2020","unstructured":"Hirano I, Furuta GT. Approaches and challenges to management of pediatric and adult patients with eosinophilic esophagitis. Gastroenterology. 2020;158(4):840\u201351. https:\/\/doi.org\/10.1053\/j.gastro.2019.09.052.","journal-title":"Gastroenterology"},{"issue":"11","key":"993_CR162","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.cgh.2018.06.005","volume":"16","author":"C Ma","year":"2018","unstructured":"Ma C, van Rhijn BD, Jairath V, et al. Heterogeneity in clinical, endoscopic, and histologic outcome measures and placebo response rates in clinical trials of eosinophilic esophagitis: a systematic review. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2018;16(11):1714-1729.e3. https:\/\/doi.org\/10.1016\/j.cgh.2018.06.005.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"6","key":"993_CR163","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/apt.12413","volume":"38","author":"ES Dellon","year":"2013","unstructured":"Dellon ES, Irani AM, Hill MR, Hirano I. Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis. Aliment Pharmacol Ther. 2013;38(6):634\u201342. https:\/\/doi.org\/10.1111\/apt.12413.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"993_CR164","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jaci.2015.03.004","volume":"135","author":"LJ Martin","year":"2015","unstructured":"Martin LJ, Franciosi JP, Collins MH, et al. Pediatric eosinophilic esophagitis symptom scores (PEESS v2.0) identify histologic and molecular correlates of the key clinical features of disease. J Allergy Clin Immunol. 2015;135(6):1519-1528.e8. https:\/\/doi.org\/10.1016\/j.jaci.2015.03.004.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"993_CR165","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaci.2018.05.014","volume":"142","author":"SS Aceves","year":"2018","unstructured":"Aceves SS, King E, Collins MH, et al. Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites. J Allergy Clin Immunol. 2018;142(1):130-138.e1. https:\/\/doi.org\/10.1016\/j.jaci.2018.05.014.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"993_CR166","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jaci.2024.04.025","volume":"154","author":"H Sato","year":"2024","unstructured":"Sato H, Dellon ES, Aceves SS, et al. Clinical and molecular correlates of the index of severity for eosinophilic esophagitis. J Allergy Clin Immunol. 2024;154(2):375-386.e4. https:\/\/doi.org\/10.1016\/j.jaci.2024.04.025.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"993_CR167","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MPG.0b013e31828f1fd2","volume":"57","author":"JP Franciosi","year":"2013","unstructured":"Franciosi JP, Hommel KA, Bendo CB, et al. PedsQL eosinophilic esophagitis module: feasibility, reliability, and validity. J Pediatr Gastroenterol Nutr. 2013;57(1):57\u201366. https:\/\/doi.org\/10.1097\/MPG.0b013e31828f1fd2.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"993_CR168","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1365-2036.2011.04791.x","volume":"34","author":"TH Taft","year":"2011","unstructured":"Taft TH, Kern E, Kwiatek MA, Hirano I, Gonsalves N, Keefer L. The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health-related quality of life. Aliment Pharmacol Ther. 2011;34(7):790\u20138. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04791.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"993_CR169","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1053\/j.gastro.2021.06.023","volume":"161","author":"TH Taft","year":"2021","unstructured":"Taft TH, Carlson DA, Simons M, et al. Esophageal hypervigilance and symptom-specific anxiety in patients with eosinophilic esophagitis. Gastroenterology. 2021;161(4):1133\u201344. https:\/\/doi.org\/10.1053\/j.gastro.2021.06.023.","journal-title":"Gastroenterology"},{"issue":"6","key":"993_CR170","doi-asserted-by":"publisher","first-page":"853","DOI":"10.14309\/ajg.0000000000000597","volume":"115","author":"CC Reed","year":"2020","unstructured":"Reed CC, Corder SR, Kim E, et al. Psychiatric comorbidities and psychiatric medication use are highly prevalent in patients with eosinophilic esophagitis and associate with clinical presentation. Am J Gastroenterol. 2020;115(6):853\u20138. https:\/\/doi.org\/10.14309\/ajg.0000000000000597.","journal-title":"Am J Gastroenterol"},{"key":"993_CR171","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/JAA.S193045","volume":"12","author":"TH Taft","year":"2019","unstructured":"Taft TH, Guadagnoli L, Edlynn E. Anxiety and depression in eosinophilic esophagitis: a scoping review and recommendations for future research. J Asthma Allergy. 2019;12:389\u201399. https:\/\/doi.org\/10.2147\/JAA.S193045.","journal-title":"J Asthma Allergy"},{"issue":"8","key":"993_CR172","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.gastha.2024.07.015","volume":"3","author":"BD Gold","year":"2024","unstructured":"Gold BD, Goodwin B, Davis K, et al. Health-related quality of life and perceived stigma in eosinophilic esophagitis: a real-world, US, web-based survey. Gastro Hep Adv. 2024;3(8):1087\u201397. https:\/\/doi.org\/10.1016\/j.gastha.2024.07.015.","journal-title":"Gastro Hep Adv"},{"issue":"4","key":"993_CR173","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/MPG.0b013e31829ce5ad","volume":"57","author":"RF Harris","year":"2013","unstructured":"Harris RF, Menard-Katcher C, Atkins D, Furuta GT, Klinnert MD. Psychosocial dysfunction in children and adolescents with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57(4):500\u20135. https:\/\/doi.org\/10.1097\/MPG.0b013e31829ce5ad.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"12","key":"993_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41424-018-0074-8","volume":"9","author":"T Greuter","year":"2018","unstructured":"Greuter T, Alexander JA, Straumann A, Katzka DA. Diagnostic and therapeutic long-term management of eosinophilic esophagitis: current concepts and perspectives for steroid use. Clin Transl Gastroenterol. 2018;9(12):e212. https:\/\/doi.org\/10.1038\/s41424-018-0074-8.","journal-title":"Clin Transl Gastroenterol"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-00993-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-025-00993-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-025-00993-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:15:05Z","timestamp":1767856505000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13223-025-00993-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":174,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1186\/s13223-025-00993-0","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"7 November 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Equal contribution note was corrected.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research ethics board approval was obtained for the study from the BC Children\u2019s and Women\u2019s Hospital Research ethics board (H24-00065). Full details of methods are available in Supplementary Appendix\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The following authors have received grants in the past 36\u00a0months for other projects unrelated to this one: TX from Abvie and Pfizer. CM has received grant from AbbVie, Eli Lilly, Ferring, Pfizer; EC from DBV Technologies; SCE from Sanofi; SJ from AMOSO; DA from Regeneron and Sanofi; NT from Sanofi\/Regeneron, AVIR, AstraZeneca, Amgen, Medexus; SM from Sanofi, Avir Pharma, Medtronic, Boston Scientifi; MG from Dr. Falk, BMS, Eupraxia, Celgene. The following authors have received consulting fees: KG from Avir Pharma; TX from Abbvie, Avir Pharma, Ferring, Janssen, Knight Pharmaceuticals, Lupin Pharma, Pfizer, Pharmacosmos, Portola, Takeda, Warner Chilcott (Activis, Allergan); GL from Sanofi, Novartis, Takeda, CSL Behring, Astra Zeneca, Amgen, GSK, Incyte, Biocryst; CM from AbbVie, Alimentiv, Amgen, AVIR Pharma Inc, Bristol Myers Squibb, Celltrion, Eli Lilly, Ferring, Forte Biosciences, Fresenius Kabi, Gilead, Janssen, McKesson, Mirador Therapeutics, Mylan, Pendopharm, Pfizer, Prometheus Biosciences Inc., Roche, Sanofi, Takeda, Tillotts Pharma; DMR from Knight Therapeutics and Sanofi; TVL from ALK-Abell\u00f3 and Pfizer; SJ at CADTH; SM from Sanofi, Avir; WA from Abbvie, Avir, Amgen, Celltrion, Janssen, Pfizer, Sanofi, Takeda; MG from Sanfi\/Regeneron, Eupraxia, AstraZeneca, Takeda, Bausch Health, Pentax, AVIR Pharma; MM from Sanofi. The following authors have received Payment or honoraria for lectures, presentations, speakers\u2019 bureaus, manuscript writing or educational events: KG from Sanofi\/Regeneron, Janssen, Mead Johnson Nutrition; SG from Sanofi-Aventis; Abvie and Amgen; TX from Abbvie, Avir Pharma, Converge, Ferring, Janssen, ICB, Knight Pharmaceuticals, Life Labs, Lupin Pharma, Pendopharm, Pfizer, Pentax, Pharmacosmos, Portola, Procter and Gamble, Sanofi, Shire (Takeda), Warner Chilcott Activis, Allergan; GL from Biocryst, Sanofi, Novartis, Amgen, Astra Xeneca, Takeda; JB from Bayer Inc.; CM from AbbVie, Amgen, AVIR Pharma Inc, Alimentiv, Bristol Myers Squibb, Eli Lilly, Ferring, Fresenius Kabi, Janssen, Merck, Organon, Pendopharm, Pfizer, Sanofi, Takeda, Tillotts Pharma; DMR from Knight Therapeutics and Bausch; HHK from Sanofi and Avir; SJ from GSK, Abbvie, Sanofi, Astra Zeneca, L\u2019oreal; WA from Abbvie, Avir, Amgen, Celltrion, Janssen, Pfizer, Sanofi, Takeda; MM from Sanofi, Nutrica. The following authors have received payment for expert testimony: TX from College of Physicians and Surgeons Ontario. The following authors have received Support for attending meetings and\/or travel: TX from Knight Pharmaceuticals; DB from AbbVie; TVL from CSACI; DA from Regeneron and Sanofi; NT from Medexus. SJ has received a patent for an online course \u2013 eczema explained. The following authors have received funds for Participation on a Data Safety Monitoring Board or Advisory Board: KG for Sanofi\/Regeneron; TX from Abbvie, Ferring, Knight Pharmaceuticals, Pfizer, Pharmacosmos, Portola, Takeda, Warner Chilcott (Activis, Allergan); VA from Sanofi; CM from Eupraxia Pharmaceuticals; EC is an advisory board member at ALK, Alladapt, AstraZeneca, Avir Pharma, Bausch Health, Sanofi; HHK is an advisory board member at Sanofi; MS Sanofi Advisory Board Meeting (November 2022); SBC from Medexus, Sanofi, Bausch Health, Pfizer, BioCryst, Alladapt; HP from Adboard for Tremfya (Janssen); NT from Sanofi\/Regeneron and AVIR; SM from Sanofi and Avir; MG for Sanofi\/Regeneron, AVIR Pharma.The following authors hold a Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid; TX for College of Physicians and Surgeons of Ontario; BAW as the President-elect, Council for Pediatric Nutrition Professionals of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and Chair, Trainee Leadership Committee of the Canadian Nutrition Society; EC at CSACI (Canadian Society of Allergy & Clinical Immunology); TVL for CSACI; SJ at CSACI, OMA (Ontario Medical Association) and a member of the\n                      Allergy, Asthma and Clinical Allergy\n                      Editorial Board (excluded from peer-review process). CM received royalties or licenses from Springer Publishing. SG has an equity stake in Volo Healthcare. The remaining authors (BAP, HA, AT, HH, JLB, JG, JG, SC, MV, DED) have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}